The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001794:Blood Pressure / Q000187:drug effects; D001830:Body Surface Area; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002339:Carotid Arteries / Q000502:physiology; D002490:Central Nervous System / Q000187:drug effects; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004285:Dogs; D004298:Dopamine / Q000502:physiology; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006834:Hydrazines / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D011941:Receptors, Adrenergic; D013237:Stereoisomerism; D013268:Stimulation, Chemical; D014655:Vascular Resistance / Q000187:drug effects
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D011941:Receptors, Adrenergic; D004295:Dihydroxyphenylalanine; D006220:Haloperidol; D004298:Dopamine